Send me a link:

*Text messaging rates may apply.

 Dow Down0.06% Nasdaq Up0.51%

Biogen Idec Inc. (BIIB)

-NasdaqGS
346.20 Up 4.47(1.31%) 10:37AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 2,129,751   1,965,850   1,827,780   1,723,473  
Cost of Revenue279,245  258,553  234,696  230,728  
Gross Profit 1,850,506   1,707,297   1,593,084   1,492,745  
Operating Expenses
Research Development528,884  422,233  410,017  327,463  
Selling General and Administrative510,875  525,293  405,487  425,849  
Non Recurring -   -   -   -  
Others143,258  109,424  99,998  82,225  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 671,348   657,926   684,531   662,527  
Income from Continuing Operations
Total Other Income/Expenses Net(1,742)2,174  2,309  (5,109)
Earnings Before Interest And Taxes669,606  660,100  686,840  657,418  
Interest Expense -   -   -   -  
Income Before Tax669,606  660,100  686,840  657,418  
Income Tax Expense178,414  190,261  186,105  159,140  
Minority Interest228   -   -   -  
Net Income From Continuing Ops483,815  464,885  494,565  495,989  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 479,956   457,306   487,616   490,670  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 479,956   457,306   487,616   490,670  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.